LESCOL 94% SALES GROWTH WORLDWIDE SHOWS VITALITY OF LIPID-LOWERING MARKET; MERCK's ZOCOR UP 79% IN U.S. TO $375 MIL., BUT 1ST QUARTER LAGS 4TH QUARTER

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".